These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9813316)

  • 1. Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.
    Minger SL; Geddes JW; Holtz ML; Craddock SD; Whiteheart SW; Siman RG; Pettigrew LC
    Brain Res; 1998 Nov; 810(1-2):181-99. PubMed ID: 9813316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate receptor antagonists modulate heat shock protein response in focal brain ischemia.
    Pettigrew LC; Holtz ML; Minger SL; Craddock SD
    Neurol Res; 2003 Mar; 25(2):201-7. PubMed ID: 12635523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microtubular proteolysis in focal cerebral ischemia.
    Pettigrew LC; Holtz ML; Craddock SD; Minger SL; Hall N; Geddes JW
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1189-202. PubMed ID: 8898691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain.
    Nellgård B; Wieloch T
    Acta Physiol Scand; 1992 Dec; 146(4):497-503. PubMed ID: 1283483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
    Jolkkonen J; Puurunen K; Koistinaho J; Kauppinen R; Haapalinna A; Nieminen L; Sivenius J
    Eur J Pharmacol; 1999 May; 372(1):31-6. PubMed ID: 10374712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats.
    Miyabe M; Kirsch JR; Nishikawa T; Koehler RC; Traystman RJ
    Crit Care Med; 1997 Jun; 25(6):1037-43. PubMed ID: 9201058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats.
    Suzuki Y; Takagi Y; Nakamura R; Hashimoto K; Umemura K
    Brain Res; 2003 Feb; 964(1):116-20. PubMed ID: 12573519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
    Yokoyama O; Mizuno H; Komatsu K; Akino H; Tanase K; Namiki M
    J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia.
    Hong SC; Lanzino G; Goto Y; Kang SK; Schottler F; Kassell NF; Lee KS
    Brain Res; 1994 Oct; 661(1-2):43-50. PubMed ID: 7834383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia.
    DeGraba TJ; Ostrow P; Hanson S; Grotta JC
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):262-8. PubMed ID: 8113322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic antagonism: effects on lidocaine-induced seizures in the rat.
    McFarlane C; Warner DS; Dexter F; Todd MM
    Anesth Analg; 1994 Oct; 79(4):701-5. PubMed ID: 7943778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
    von Euler M; Seiger A; Holmberg L; Sundström E
    Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
    Lo EH; Pierce AR; Mandeville JB; Rosen BR
    Stroke; 1997 Feb; 28(2):439-46; discussion 446-7. PubMed ID: 9040703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
    Okada M; Ueda H; Kometani M; Nakao K
    Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil.
    Judge ME; Sheardown MJ; Jacobsen P; Honoré T
    Neurosci Lett; 1991 Dec; 133(2):291-4. PubMed ID: 1667818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
    Umemura K; Shimakura A; Nakashima M
    Brain Res; 1997 Oct; 773(1-2):61-5. PubMed ID: 9409705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid in the gerbil model of transient global cerebral ischemia.
    Okada M; Ueda H; Kometani M; Nakao K; Kohjimoto Y; Takahashi I; Tanaka I
    Arzneimittelforschung; 1997 Jun; 47(6):700-2. PubMed ID: 9239445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
    Hao JX; Xu XJ
    Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.